Luteolin suppresses cancer cell proliferation by targeting vaccinia-related kinase 1

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Kim, Ye Seul ^a   Kim, Seong Hoon ^a   Shin, Joon ^b   Harikishore, Amaravadhi ^b   Lim, Jong Kwan ^a   Jung, Youngseob ^a   Lyu, Ha Na ^a   Baek, Nam In ^c   Choi, Kwan Yong ^a   Yoon, Ho Sup ^b   Kim, Kyong Tai ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BARRIER TO AUTOINTEGRATION FACTOR; HISTONE H3; LUTEOLIN; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; VACCINIA RELATED KINASE 1; ANTINEOPLASTIC AGENT; BANF1 PROTEIN, HUMAN; DNA BINDING PROTEIN; HISTONE; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; VRK1 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CATALYSIS; CELL CYCLE CHECKPOINT; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; EMBRYO; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; ENZYME ACTIVE SITE; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CATALYTIC DOMAIN; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; HISTONES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUTEOLIN; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 84907930167     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109655     Document Type: Article

References (51)

1. Perez de Castro I, de Carcer G, Montoya G, Malumbres M (2008) Emerging cancer therapeutic opportunities by inhibiting mitotic kinases. Curr Opin Pharmacol 8: 375-383.
2. Manchado E, Guillamot M, Malumbres M (2012) Killing cells by targeting mitosis. Cell Death Differ 19: 369-377.
3. Chan KS, Koh CG, Li HY (2012) Mitosis-targeted anti-cancer therapies: Where they stand. Cell Death Dis 3: E411.
4. Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3: 421-429.
5. Bin Z, Xiubin G, Uppalapati U, Ashwell MA, Leggett DS, et al. (2008) Highcontent fluorescent-based assay for screening activators of DNA damage checkpoint pathways. J Biomol Screen 13: 538-543.
6. Ashwell S, Zabludoff S (2008) DNA damage detection and repair pathways- recent advances with inhibitors of checkpoint kinases in cancer therapy. Clin Cancer Res 14: 4032-4037.
7. Valbuena A, Sanz-Garcia M, Lopez-Sanchez I, Vega FM, Lazo PA (2011) Roles of VRK1 as a new player in the control of biological processes required for cell division. Cell Signal 23: 1267-1272.
8. Santos CR, Rodriguez-Pinilla M, Vega FM, Rodriguez-Peralto JL, Blanco S, et al. (2006) VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma. Mol Cancer Res 4: 177- 185.
9. Nezu J, Oku A, Jones MH, Shimane M (1997) Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics 45: 327-331.
10. Kang TH, Park DY, Choi YH, Kim KJ, Yoon HS, et al. (2007) Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells. Mol Cell Biol 27: 8533-8546.
11. Kang TH, Park DY, Kim W, Kim KT (2008) VRK1 phosphorylates CREB and mediates CCND1 expression. J Cell Sci 121: 3035-3041.
12. Nichols RJ, Wiebe MS, Traktman P (2006) The vaccinia-related kinases phosphorylate the N9 terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol Biol Cell 17: 2451-2464.
13. Segura-Totten M, Kowalski AK, Craigie R, Wilson KL (2002) Barrier-toautointegration factor: Major roles in chromatin decondensation and nuclear assembly. J Cell Biol 158: 475-485.
14. Haraguchi T, Kojidani T, Koujin T, Shimi T, Osakada H, et al. (2008) Live cell imaging and electron microscopy reveal dynamic processes of BAF-directed nuclear envelope assembly. J Cell Sci 121: 2540-2554.
15. Jeong MW, Kang TH, Kim W, Choi YH, Kim KT (2013) Mitogen-activated protein kinase phosphatase 2 regulates histone H3 phosphorylation via interaction with vaccinia-related kinase 1. Mol Biol Cell 24: 373-384.
16. Kim W, Chakraborty G, Kim S, Shin J, Park CH, et al. (2012) Macro histone H2A1.2 (macroH2A1) protein suppresses mitotic kinase VRK1 during interphase. J Biol Chem 287: 5278-5289.
17. Choi YH, Park CH, Kim W, Ling H, Kang A, et al. (2010) Vaccinia-related kinase 1 is required for the maintenance of undifferentiated spermatogonia in mouse male germ cells. PLoS One 5: E15254.
18. Kim J, Choi YH, Chang S, Kim KT, Je JH (2012) Defective folliculogenesis in female mice lacking Vaccinia-related kinase 1. Sci Rep 2: 468.
19. Choi YH, Lim JK, Jeong MW, Kim KT (2012) HnRNP A1 phosphorylated by VRK1 stimulates telomerase and its binding to telomeric DNA sequence. Nucleic Acids Res 40: 8499-8518.
20. Vega FM, Sevilla A, Lazo PA (2004) p53 Stabilization and accumulation induced by human vaccinia-related kinase 1. Mol Cell Biol 24: 10366-10380.
21. Lopez-Sanchez I, Sanz-Garcia M, Lazo PA (2009) Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation. Mol Cell Biol 29: 1189-1201.
22. Valbuena A, Lopez-Sanchez I, Lazo PA (2008) Human VRK1 is an early response gene and its loss causes a block in cell cycle progression. PLoS One 3: E1642.
23. Sanz-Garcia M, Monsalve DM, Sevilla A, Lazo PA (2012) Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage. J Biol Chem 287: 23757-23768.
24. Park CH, Choi BH, Jeong MW, Kim S, Kim W, et al. (2011) Protein kinase Cdelta regulates vaccinia-related kinase 1 in DNA damage-induced apoptosis. Mol Biol Cell 22: 1398-1408.
25. Vazquez-Cedeira M, Barcia-Sanjurjo I, Sanz-Garcia M, Barcia R, Lazo PA (2011) Differential inhibitor sensitivity between human kinases VRK1 and VRK2. PLoS One 6: E23235.
26. Lopez-Lazaro M (2009) Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 9: 31-59.
27. Lin YS, Tsai PH, Kandaswami CC, Cheng CH, Ke FC, et al. (2011) Effects of dietary flavonoids, luteolin, and quercetin on the reversal of epithelialmesenchymal transition in A431 epidermal cancer cells. Cancer Sci 102: 1829-1839.
28. Lin Y, Shi R, Wang X, Shen HM (2008) Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8: 634-646.
29. Seelinger G, Merfort I, Schempp CM (2008) Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med 74: 1667-1677.
30. Seelinger G, Merfort I, Wolfle U, Schempp CM (2008) Anti-carcinogenic effects of the flavonoid luteolin. Molecules 13: 2628-2651.
31. Kim W, Lyu HN, Kwon HS, Kim YS, Lee KH, et al. (2013) Obtusilactone B from Machilus Thunbergii targets barrier-to-autointegration factor to treat cancer. Mol Pharmacol 83: 367-376.
32. Kim S, Park DY, Lee D, Kim W, Jeong YH, et al. (2014) Vaccinia-related kinase 2 mediates accumulation of polyglutamine aggregates via negative regulation of the chaperonin TRiC. Mol Cell Biol 34: 643-652.
33. Byun S, Lee KW, Jung SK, Lee EJ, Hwang MK, et al. (2010) Luteolin inhibits protein kinase C(epsilon) and c-Src activities and UVB-induced skin cancer. Cancer Res 70: 2415-2423.
34. Shin J, Chakraborty G, Bharatham N, Kang C, Tochio N, et al. (2011) NMR solution structure of human vaccinia-related kinase 1 (VRK1) reveals the Cterminal tail essential for its structural stability and autocatalytic activity. J Biol Chem 286: 22131-22138.
35. George VC, Naveen Kumar DR, Suresh PK, Kumar S, Kumar RA (2013) Comparative Studies to Evaluate Relative in vitro Potency of Luteolin in Inducing Cell Cycle Arrest and Apoptosis in HaCaT and A375 Cells. Asian Pac J Cancer Prev 14: 631-637.
36. Lim do Y, Jeong Y, Tyner AL, Park JH (2007) Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. Am J Physiol Gastrointest Liver Physiol 292: G66-75.
37. Chang J, Hsu Y, Kuo P, Kuo Y, Chiang L, et al. (2005) Increase of Bax/Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. Life Sci 76: 1883-1893.
38. Cai X, Ye T, Liu C, Lu W, Lu M, et al. (2011) Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells. Toxicol In Vitro 25: 1385-1391.
39. Ong CS, Zhou J, Ong CN, Shen HM (2010) Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3beta-Cyclin D1 pathway. Cancer Lett 298: 167-175.
40. Xie F, Lang Q, Zhou M, Zhang H, Zhang Z, et al. (2012) The dietary flavonoid luteolin inhibits Aurora B kinase activity and blocks proliferation of cancer cells. Eur J Pharm Sci 46: 388-396.
41. Margalit A, Segura-Totten M, Gruenbaum Y, Wilson KL (2005) Barrier-toautointegration factor is required to segregate and enclose chromosomes within the nuclear envelope and assemble the nuclear lamina. Proc Natl Acad Sci U S A 102: 3290-3295.
42. Lancaster OM, Cullen CF, Ohkura H (2007) NHK-1 phosphorylates BAF to allow karyosome formation in the Drosophila oocyte nucleus. J Cell Biol 179: 817-824.
43. Gorjanacz M, Klerkx EP, Galy V, Santarella R, Lopez-Iglesias C, et al. (2007) Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in postmitotic nuclear envelope assembly. Embo j 26: 132-143.
44. Molitor TP, Traktman P (2014) Depletion of the protein kinase VRK1 disrupts nuclear envelope morphology and leads to BAF retention on mitotic chromosomes. Mol Biol Cell.
45. Kim IJ, Quigley D, To MD, Pham P, Lin K, et al. (2013) Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas. Nat Commun 4: 1701.
46. Williams GH, Stoeber K (2012) The cell cycle and cancer. J Pathol 226: 352- 364.
47. Martin KJ, Patrick DR, Bissell MJ, Fournier MV (2008) Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS One 3: E2994.
48. Molitor TP, Traktman P (2013) Molecular genetic analysis of VRK1 in mammary epithelial cells: depletion slows proliferation in vitro and tumor growth and metastasis in vivo. Oncogenesis 2: E48.
49. Weng CJ, Yen GC (2012) Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev 31: 323-351.
50. Korkina LG, Pastore S, Dellambra E, De Luca C (2013) New molecular and cellular targets for chemoprevention and treatment of skin tumors by plant polyphenols: A critical review. Curr Med Chem 20: 852-868.
51. Darvesh AS, Bishayee A (2013) Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer. Nutr Cancer 65: 329-344.